Rethinking Health State Valuation: Moving Beyond ‘Dead’ as an Anchor

By Charmi Patel

June 13, 2024

Introduction

Health state valuation (HSV) is a crucial aspect of healthcare assessments. In traditional practice, valuations have historically anchored around ‘dead’. However, recent discussions suggest that this practice may be unnecessary and problematic. There might be implications of removing ‘dead’ from HSV but it proposes new approaches for future research.

The Problem with ‘Dead’ as an Anchor

Anchoring HSV at ‘dead’ has been a standard practice. However, this approach has several issues. Firstly, it introduces bias into people’s health state preferences. When ‘dead’ is used as a reference point, it can skew the valuation of health states. This bias affects all HSVs and can lead to inaccurate assessments.

Moreover, the distinction between states better or worse than dead (BTD and WTD) is problematic. These terms hold significant meaning outside of HSV, such as in discussions about physician-assisted dying. Removing ‘dead’ from HSV allows for more precise and meaningful usage of these terms.

Implications for Health State Valuation

Removing ‘dead’ from HSV changes how we should discuss and interpret these valuations. Firstly, new approaches to valuation are needed. Excluding ‘dead’ does not solve the challenge of calculating HSVs for health states that generate very high shortfalls (VHY) greater than one. Traditional time trade-off (TTO) methods cannot offer shorter time periods in full health to generate such shortfalls. Hence, we must explore alternative methods.

Exploring New Valuation Methods

One potential approach is the use of chained TTO. This method involves a sequence of periods, some generating VHY shortfalls due to poor health and others generating quality-adjusted life years (QALYs) in full health at non-concurrent times. Full health may occur before or after ill-health, known as ‘lead time’ or ‘lag time’. Another option is to identify shortfalls relative to a hypothetical life expectancy. These methods must ensure plausible scenarios for respondents and account for time preference.

Furthermore, one can derive insights from other methodologies, like engaging in kaizen tasks. These tasks involve continuous improvement and can provide valuable insights into new valuation methods.

Figure 2: Chained TTO vs Conventional TTO
Figure 2: Chained TTO vs Conventional TTO

Assessing the Importance of Negative States

In light of this reinterpretation, it is essential to assess the importance of negative states. The frequency of states experiencing a shortfall greater than one VHY, how often practitioners observe these states in practice, and the relevance of these states to health technology assessment remain unknown. Understanding these characteristics is crucial for accurately modelling negative values.

Most valuation studies have used the EQ-5D as an example. However, this analysis applies to any patient-reported outcome measure or set of HSVs used to estimate QALYs. Negative HSVs can offer valuable insights into health states, but individuals should avoid labeling them as worse than dead (WTD). Researchers should abandon the search for a state with an HSV equal to zero. QALYs represent the value of a healthy year, which has no meaningful relation to the value of dying or being dead.

Conclusion

The practice of anchoring HSV at ‘dead’ is outdated and introduces bias into health state valuations. Removing ‘dead’ from HSV allows for more accurate and meaningful assessments. Future research should focus on developing new valuation methods and understanding the importance of negative states. By doing so, we can improve the accuracy and relevance of health state valuations in healthcare assessments.

Reference url

Recent Posts

modifiable risk factors
        

Targeting Shared Risk Pathways to Prevent Stroke, Dementia, and Depression

🧠 What if addressing just a few key lifestyle factors could significantly reduce the risk of stroke, dementia, and depression in older adults?

A recent systematic review has identified 17 **modifiable risk factors**, revealing the interconnected nature of these age-related brain diseases and offering crucial insights for preventive strategies. By focusing on aspects such as blood pressure management, nutrition, and physical activity, we can enhance quality of life for our aging population.

Dive into the article to explore how these findings could shape future healthcare models.

#SyenzaNews #HealthEconomics #HealthcareInnovation #DigitalTransformation

drug price regulation
      

Navigating Drug Price Regulation: Evaluating the Executive Order’s Potential Impacts and Challenges

💊 Curious about the future of drug pricing in the U.S.?

The recent executive order aims to tackle escalating prescription drug costs through measures like international reference pricing and enhanced transparency. However, the implications of these policies could be more complex than anticipated, with potential risks to market access and innovation.

Dive into the article for a detailed analysis of how these regulations could shape the pharmaceutical landscape and what it means for healthcare access in the U.S.

#SyenzaNews #pharmaceuticals #healthcarepolicy

AI Patient Education
       

AI Patient Education: Evaluating ChatGPT and Gemini for Pediatric Condition Materials

🤔 Are AI solutions ready to revolutionize pediatric patient education?

A recent study compared ChatGPT and Gemini in generating educational materials for common pediatric conditions, revealing intriguing insights into content depth, readability, and reliability. While both tools have their merits, there’s significant room for improvement in making AI-generated content accessible and effective for all families.

Curious to learn more about the implications for health literacy and the future of AI in healthcare? Click to read the full article!

#SyenzaNews #AIinHealthcare #HealthTech #DigitalTransformation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.